MedPath

Xellia Pharmaceuticals USA LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

30

FDA:30

Drug Approvals

Vancomycin Hydrochloride

Approval Date
Dec 12, 2023
FDA

Daptomycin

Approval Date
Nov 17, 2023
FDA

Daptomycin

Approval Date
Nov 7, 2023
FDA

Carboprost Tromethamine

Approval Date
Nov 1, 2023
FDA

Daptomycin

Approval Date
Oct 11, 2023
FDA

Vancomycin Hydrochloride

Approval Date
Sep 15, 2023
FDA

Daptomycin

Approval Date
Aug 4, 2023
FDA

Bupivacaine HCl

Approval Date
Jun 9, 2023
FDA

Bupivacaine HCl

Approval Date
Jun 9, 2023
FDA

Acetylcysteine

Approval Date
May 31, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.